Key facts
- This page summarizes Lisa Wright's Form 4 filing for Vericel Corp (VCEL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Apr 2023, 16:04.
Lisa Wright - 27 Apr 2023 Form 4 Insider Report for Vericel Corp (VCEL)
- Reporting relationship
- Director
- Issuer ticker
- VCEL
- Reported as of
- 27 Apr 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Apr 2023, 16:04:43 UTC
- Prior SEC filing
- 02 Jun 2022
- Next SEC filing
- 05 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sean Flynn, as Attorney-in-Fact for Lisa Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lisa Wright filed Form 4 for Vericel Corp (VCEL) on 28 Apr 2023.
Change
- Previous filing in this sequence was filed on 02 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VCEL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,600
- Change %
- +93%
- Price
- Shares after
- 5,384
- Date
- 27 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VCEL
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,600
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 27 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,600
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 27, 2022.
Footnote F2
Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
Footnote F3
These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022.
Footnote F4
No expiration date for this type of award.